Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Comment by SamV21on Dec 13, 2021 3:29pm
128 Views
Post# 34226317

RE:Is Reduvo going to cover the 96,550,606 deficit Tetra has ?

RE:Is Reduvo going to cover the 96,550,606 deficit Tetra has ?and pay for Qixleef Phase 2,3 and 4 to become something and pay Intelgenx and pay Panag's 1,200,000 a year till 2029 and 15,000,000 if it can't.  I read through the  management and discussion book that arrived last week spent an hour searching , no where does it state the company CEO name and no where does it say how much he gets paid , just doesn't seem very transparent or respectful to shareholders, red flag.
You all better read page 7 going concern.Reduvo or bust, don't even think, talk  or worry about anything else they are working on, they will be done, we could lose all our money, now that we are at .17 cents the latest pump is well it is Bio tech risky you know, yet you were the ones name calling the real investors when they raised questions and had concerns.How are those warrants doing you all you  pumpers were bragging about ?
Reduvo will help but it is not enough ,too little too late. 
<< Previous
Bullboard Posts
Next >>